|
1
|
World Health Organization and
International Agency for Research on Cancer. World Cancer Report
2008. International Agency for Research on Cancer; Lyon: pp. 1–511.
2008
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bello IO, Soini Y and Salo T: Prognostic
evaluation of oral tongue cancer: means, markers and perspectives
(II). Oral Oncol. 46:636–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giudice FS, Dal Vechio AM, Abrahao AC,
Sperandio FF and dos Pinto-Junior DS: Different expression patterns
of pAkt, NF-κB and cyclin D1 proteins during the invasion process
of head and neck squamous cell carcinoma: an in vitro approach. J
Oral Pathol Med. 40:405–411. 2011. View Article : Google Scholar
|
|
5
|
Squarize CH, Castilho RM, Abrahao AC,
Molinolo A, Lingen MW and Gutkind JS: PTEN deficiency contributes
to the development and progression of head and neck cancer.
Neoplasia. 15:461–471. 2013.PubMed/NCBI
|
|
6
|
Okamura H, Tsutsui H, Kashiwamura S,
Yoshimoto T and Nakanishi K: Interleukin-18: a novel cytokine that
augments both innate and acquired immunity. Adv Immunol.
70:281–312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Srivastava S, Salim N and Robertson MJ:
Interleukin-18: biology and role in the immunotherapy of cancer.
Curr Med Chem. 17:3353–3357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tschoeke SK, Oberholzer A and Moldawer LL:
Interleukin-18: a novel prognostic cytokine in bacteria-induced
sepsis. Crit Care Med. 34:1225–1233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee HR, Yoon SY, Song SB, et al:
Interleukin-18-mediated interferon-gamma secretion is regulated by
thymosin beta 4 in human NK cells. Immunobiology. 216:1155–1162.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tse BW, Russell PJ, Lochner M, Forster I
and Power CA: IL-18 inhibits growth of murine orthotopic prostate
carcinomas via both adaptive and innate immune mechanisms. PloS
One. 6:e242412011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian H, Shi G, Yang G, et al: Cellular
immunotherapy using irradiated lung cancer cell vaccine
co-expressing GM-CSF and IL-18 can induce significant antitumor
effects. BMC Cancer. 14:482014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong JL, Muthuswamy R, Bartlett DL and
Kalinski P: IL-18-based combinatorial adjuvants promote the
intranodal production of CCL19 by NK cells and dendritic cells of
cancer patients. Oncoimmunology. 2:e262452013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Korur S, Huber RM, Sivasankaran B, et al:
GSK3beta regulates differentiation and growth arrest in
glioblastoma. PloS One. 4:e74432009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Atkins RJ, Dimou J, Paradiso L, et al:
Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt
pathway in gliomas. J Clin Neurosci. 19:1558–1563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grimes CA and Jope RS: The multifaceted
roles of glycogen synthase kinase 3beta in cellular signaling. Prog
Neurobiol. 65:391–426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi-Yanaga F: Activator or
inhibitor? GSK-3 as a new drug target. Biochem Pharmacol.
86:191–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim M, Datta A, Brakeman P, Yu W and
Mostov KE: Polarity proteins PAR6 and aPKC regulate cell death
through GSK-3beta in 3D epithelial morphogenesis. J Cell Sci.
120:2309–2317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doble BW and Woodgett JR: GSK-3: tricks of
the trade for a multi-tasking kinase. J Cell Sci. 116:1175–1186.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshimura T, Kawano Y, Arimura N, Kawabata
S, Kikuchi A and Kaibuchi K: GSK-3beta regulates phosphorylation of
CRMP-2 and neuronal polarity. Cell. 120:137–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu C, Li Y, Semenov M, et al: Control of
beta-catenin phosphorylation/degradation by a dual-kinase
mechanism. Cell. 108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu G and He X: Threonine 41 in
beta-catenin serves as a key phosphorylation relay residue in
beta-catenin degradation. Biochemistry. 45:5319–5323. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu Z, Sun D and Young W: Lithium promotes
neural precursor cell proliferation: evidence for the involvement
of the non-canonical GSK-3β-NF-AT signaling. Cell Biosci. 1:182011.
View Article : Google Scholar
|
|
23
|
Zhang X, Chen T, Zhang J, et al: Notch1
promotes glioma cell migration and invasion by stimulating
β-catenin and NF-κB signaling via AKT activation. Cancer Sci.
103:181–190. 2012. View Article : Google Scholar
|
|
24
|
Lu W and Li Y: Salinomycin suppresses LRP6
expression and inhibits both Wnt/β-catenin and mTORC1 signaling in
breast and prostate cancer cells. J Cell Biochem. 155:1799–1807.
2014. View Article : Google Scholar
|
|
25
|
Mishra R: Glycogen synthase kinase 3 beta:
can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wen W, Ding J, Sun W, et al: Cyclin
G1-mediated epithelial-mesenchymal transition via phosphoinositide
3-kinase/Akt signaling facilitates liver cancer progression.
Hepatology. 55:1787–1798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Han B, Sun B, Gao Y, Huang Y and Hu
M: Overexpression of interleukin-18 induces growth inhibition,
apoptosis and gene expression changes in a human tongue squamous
cell carcinoma cell line. J Int Med Res. 40:537–544. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Zheng JN, Pei DS, Sun FH, et al: Potent
antitumor efficacy of interleukin-18 delivered by conditionally
replicative adenovirus vector in renal cell carcinoma-bearing nude
mice via inhibition of angiogenesis. Cancer Biol Ther. 8:599–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mo C, Dai Y, Kang N, Cui L and He W:
Ectopic expression of human MutS homologue 2 on renal carcinoma
cells is induced by oxidative stress with interleukin-18 promotion
via p38 mitogen-activated protein kinase (MAPK) and c-Jun
N-terminal kinase (JNK) signaling pathways. J Biol Chem.
287:19242–19254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nilkaeo A and Bhuvanath S: Role of
interleukin-18 in modulation of oral carcinoma cell proliferation.
Mediators Inflamm. 2006:671202006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shiratori I, Suzuki Y, Oshiumi H, et al:
Recombinant interleukin-12 and interleukin-18 antitumor therapy in
a guinea-pig hepatoma cell implant model. Cancer Sci. 98:1936–1942.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Kobayashi Y, Sato A, Kobayashi E
and Murakami T: Synergistic anti-tumor effect by combinatorial
gene-gun therapy using IL-23 and IL-18 cDNA. J Dermatol Sci.
36:66–68. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chaudhry UI, Kingham TP, Plitas G, Katz
SC, Raab JR and DeMatteo RP: Combined stimulation with
interleukin-18 and CpG induces murine natural killer dendritic
cells to produce IFN-gamma and inhibit tumor growth. Cancer Res.
66:10497–10504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu TP, Shen H, Liu LX and Shu YQ:
Plumbagin from Plumbago Zeylanica L induces apoptosis in human
non-small cell lung cancer cell lines through NF-κB inactivation.
Asian Pac J Cancer Prev. 14:2325–2331. 2013. View Article : Google Scholar
|
|
36
|
Hosotani Y, Kashiwamura S, Kimura-Shimmyo
A, et al: Interleukin-18 prevents apoptosis via PI3K/Akt pathway in
normal human keratinocytes. J Dermatol. 35:514–524. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chandrasekar B, Vemula K, Surabhi RM, et
al: Activation of intrinsic and extrinsic proapoptotic signaling
pathways in interleukin-18-mediated human cardiac endothelial cell
death. J Biol Chem. 279:20221–20233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
John T, Kohl B, Mobasheri A, Ertel W and
Shakibaei M: Interleukin-18 induces apoptosis in human articular
chondrocytes. Histol Histopathol. 22:469–482. 2007.PubMed/NCBI
|
|
39
|
Jin H, Liu AD, Holmberg L, et al: The role
of sulfur dioxide in the regulation of mitochondrion-related
cardiomyocyte apoptosis in rats with isopropylarterenol-induced
myocardial injury. Int J Mol Sci. 14:10465–10482. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Broughton BR, Reutens DC and Sobey CG:
Apoptotic mechanisms after cerebral ischemia. Stroke. 40:e331–339.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schoenborn JR and Wilson CB: Regulation of
interferon-gamma during innate and adaptive immune responses. Adv
Immun. 96:41–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu G, Li Y, Yoshimoto K, et al:
2,3,7,8-Tetrachlorodibenzo-pdioxin stimulates proliferation of HAPI
microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
Toxicol Lett. 224:362–370. 2014. View Article : Google Scholar
|
|
43
|
Bienvenu F, Jirawatnotai S, Elias JE, et
al: Transcriptional role of cyclin D1 in development revealed by a
genetic-proteomic screen. Nature. 463:374–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Motokura T, Bloom T, Kim HG, et al: A
novel cyclin encoded by a bcl1-linked candidate oncogene. Nature.
350:512–515. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Witzel II, Koh LF and Perkins ND:
Regulation of cyclin D1 gene expression. Biochem Soc Trans.
38:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Beurel E and Jope RS: The paradoxical pro-
and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic
apoptosis signaling pathways. Prog Neurobiol. 79:173–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin
O and Woodgett JR: Requirement for glycogen synthase kinase-3beta
in cell survival and NF-kappaB activation. Nature. 406:86–90. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Belkhiri A, Dar AA, Zaika A, Kelley M and
El-Rifai W: t-Darpp promotes cancer cell survival by up-regulation
of Bcl2 through Akt-dependent mechanism. Cancer Res. 68:395–403.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang Q, Fu H, Zhang H, et al: Hydrogen
sulfide preconditioning protects rat liver against
ischemia/reperfusion injury by activating Akt-GSK-3β signaling and
inhibiting mitochondrial permeability transition. PLoS One.
8:e744222013. View Article : Google Scholar
|
|
51
|
Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET
and Yu Q: Pharmacologic modulation of glycogen synthase
kinase-3beta promotes p53-dependent apoptosis through a direct
Bax-mediated mitochondrial pathway in colorectal cancer cells.
Cancer Res. 65:9012–9020. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee Y, Dominy JE, Choi YJ, et al: Cyclin
D1-Cdk4 controls glucose metabolism independently of cell cycle
progression. Nature. 510:547–551. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Takahashi-Yanaga F and Sasaguri T:
GSK-3beta regulates cyclin D1 expression: a new target for
chemotherapy. Cell Signal. 20:581–589. 2008. View Article : Google Scholar
|
|
54
|
Ye X, Guo Y, Zhang Q, et al: βKlotho
suppresses tumor growth in hepatocellular carcinoma by regulating
Akt/GSK-3β/cyclin D1 signaling pathway. PLoS One. 8:e556152013.
View Article : Google Scholar
|
|
55
|
Blanco J, Mulero M, Domingo JL and Sanchez
DJ: Perinatal exposure to BDE-99 causes decreased protein levels of
cyclin D1 via GSK3β activation and increased ROS production in rat
pup livers. Toxicol Sci. 137:491–498. 2014. View Article : Google Scholar
|
